In HCC, SOX6 inhibits NPM1 via repressing c-MYC, which subsequently stabilizes and activates p53 via promoting the formation of the p14ARF/HDM2/p53 complex, ultimately inhibiting HCC proliferation [126]. Here, NPM1 is linked to hepatocellular carcinoma.